Regulatory News
Wednesday, February 1, 2017
BRIEF-Zimmer Biomet announces FDA approval of knee osteoarthritis vaccine
* Zimmer Biomet announces FDA approval of expanded 26-week
efficacy claim for gel-one cross-linked hyaluronate for
treatment of pain associated with knee osteoarthritis
Source text for Eikon:...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment